Investigating Real-World Benztropine Usage Patterns in Movement Disorders: Claims Analysis and Health Care Provider Survey Results
Conclusions: These complementary analyses suggest that benztropine is used long-term in non-tardive dyskinesia drug-induced movement disorders and in tardive dyskinesia despite risks of worsening tardive dyskinesia or adverse effects.Prim Care Companion CNS Disord 2023;25(4):22m03472.Author affiliations are listed at the end of this article.PMID:37671827 | DOI:10.4088/PCC.22m03472
Source: Primary Care - Category: Primary Care Authors: Craig Chepke Betsy Benning Samantha Cicero Michael Hull Erika Giraldo Jason Yeaw Katharine Coyle Eric Jen Morgan Bron Source Type: research
More News: Benztropine | Dyskinesia | Health Management | Nurses | Nursing | Primary Care | Psychiatry | Schizophrenia | Study | USA Health